Literature DB >> 9038373

Expression and function of members of the cytokine receptor superfamily on breast cancer cells.

A M Douglas1, G A Goss, R L Sutherland, D J Hilton, M C Berndt, N A Nicola, C G Begley.   

Abstract

Receptors for the cytokines leukemia inhibitory factor (LIF), interleukin-6 (IL-6), oncostatin M (OSM), ciliary neurotrophic factor (CNTF) and interleukin-11 (IL-11) are members of the structurally conserved hemopoietin receptor superfamily. In addition, they all share the transmembrane signalling protein gp130. In this paper the expression and function of this family of receptors in breast cancer cells was examined. RT-PCR analyses demonstrated that gp130 was expressed in 12/12 breast cell lines and the specific receptor alpha-chains for IL-6, LIF, IL-11 and CNTF were expressed in the majority of these cell lines. This was in contrast to other hemopoietin receptors. Examination of 50 clinical samples of malignant breast tissue by RT-PCR showed a similar pattern of expression of gp130 associated receptors. Treatment of breast cancer cell lines with OSM resulted in changes in cellular morphology. Cellular proliferation was inhibited following exposure to OSM (3/4 cell lines), IL-11 (2/4 cell lines), and by IL-6 and LIF (1/4 cell lines). Cell surface binding of LIF and OSM was also documented. The expression of these receptors in 12/12 cell lines and greater than 95% of clinical samples suggests that these molecules may be important in regulating the growth of breast cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9038373     DOI: 10.1038/sj.onc.1200882

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

Review 1.  Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.

Authors:  Livio Casarini; Elisa Pignatti; Manuela Simoni
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

2.  Signaling network of Oncostatin M pathway.

Authors:  Gourav Dey; Aneesha Radhakrishnan; Nazia Syed; Joji Kurian Thomas; Arpitha Nadig; Kotteazeth Srikumar; Premendu Prakash Mathur; Akhilesh Pandey; Sze-Kwan Lin; Rajesh Raju; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2012-12-20       Impact factor: 5.782

3.  Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma.

Authors:  Yong Gu Cho; Xiaofei Chang; Il-Seok Park; Keishi Yamashita; Chunbo Shao; Patrick K Ha; Sara I Pai; David Sidransky; Myoung Sook Kim
Journal:  Int J Oncol       Date:  2011-05-23       Impact factor: 5.650

Review 4.  Minireview: Tipping the balance: ligand-independent activation of steroid receptors.

Authors:  Marcela A Bennesch; Didier Picard
Journal:  Mol Endocrinol       Date:  2015-01-27

Review 5.  Transcriptional regulation of the heat shock protein genes by STAT family transcription factors.

Authors:  A Stephanou; D S Latchman
Journal:  Gene Expr       Date:  1999

Review 6.  Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agents.

Authors:  R L Basser; C G Begley
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

7.  Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer.

Authors:  Jung Eun Shin; Su Hyung Park; Yeun Kyu Jang
Journal:  Mol Cells       Date:  2010-12-03       Impact factor: 5.034

8.  Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.

Authors:  C L Campbell; Z Jiang; D M Savarese; T M Savarese
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

9.  Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner.

Authors:  Denise Buenrostro; Kristin A Kwakwa; Nicole E Putnam; Alyssa R Merkel; Joshua R Johnson; James E Cassat; Julie A Sterling
Journal:  Bone       Date:  2018-05-16       Impact factor: 4.398

10.  Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.

Authors:  Myoung Sook Kim; Joost Louwagie; Beatriz Carvalho; Jochim S Terhaar Sive Droste; Hannah Lui Park; Young Kwang Chae; Keishi Yamashita; Junwei Liu; Kimberly Laskie Ostrow; Shizhang Ling; Rafael Guerrero-Preston; Semra Demokan; Zubeyde Yalniz; Nejat Dalay; Gerrit A Meijer; Wim Van Criekinge; David Sidransky
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.